Jianxin Qiu

2.5k total citations
65 papers, 2.0k citations indexed

About

Jianxin Qiu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Jianxin Qiu has authored 65 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Surgery and 16 papers in Cancer Research. Recurrent topics in Jianxin Qiu's work include Renal Transplantation Outcomes and Treatments (14 papers), Ubiquitin and proteasome pathways (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Jianxin Qiu is often cited by papers focused on Renal Transplantation Outcomes and Treatments (14 papers), Ubiquitin and proteasome pathways (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Jianxin Qiu collaborates with scholars based in China, United States and Taiwan. Jianxin Qiu's co-authors include Yigang Zeng, Zhihong Liu, Zuowei Li, Wei Wang, Ming Luo, Paul I. Terasaki, Bing Shen, Yu Fan, Junchao Cai and Le Tao and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Jianxin Qiu

60 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianxin Qiu China 22 1.2k 964 307 275 199 65 2.0k
Jun Tao China 26 2.1k 1.7× 1.7k 1.8× 410 1.3× 241 0.9× 187 0.9× 97 3.0k
Donge Tang China 22 1.0k 0.9× 395 0.4× 117 0.4× 413 1.5× 135 0.7× 149 1.8k
Zhongjun Wu China 24 1000 0.8× 669 0.7× 277 0.9× 384 1.4× 387 1.9× 116 1.8k
Rongxiang Han United States 24 1.2k 1.0× 465 0.5× 244 0.8× 1.9k 6.8× 240 1.2× 41 3.1k
Štefan Porubský Germany 30 722 0.6× 204 0.2× 299 1.0× 768 2.8× 170 0.9× 92 2.3k
Tian Shen China 17 971 0.8× 133 0.1× 365 1.2× 147 0.5× 205 1.0× 44 1.5k
Santiago Miriuka Argentina 26 913 0.8× 176 0.2× 484 1.6× 136 0.5× 111 0.6× 81 1.9k
Yue Yu China 22 600 0.5× 320 0.3× 328 1.1× 316 1.1× 268 1.3× 110 1.7k
Giulia Romano United States 32 3.0k 2.5× 2.6k 2.7× 185 0.6× 242 0.9× 146 0.7× 63 3.8k
Einari Aavik Finland 19 568 0.5× 176 0.2× 219 0.7× 241 0.9× 92 0.5× 46 1.5k

Countries citing papers authored by Jianxin Qiu

Since Specialization
Citations

This map shows the geographic impact of Jianxin Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianxin Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianxin Qiu more than expected).

Fields of papers citing papers by Jianxin Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianxin Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianxin Qiu. The network helps show where Jianxin Qiu may publish in the future.

Co-authorship network of co-authors of Jianxin Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianxin Qiu. A scholar is included among the top collaborators of Jianxin Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianxin Qiu. Jianxin Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ze, Ting Jiang, Jianxin Qiu, et al.. (2024). Tomatidine Alleviates Intervertebral Disc Degeneration by Activating the Nrf2/HO-1/GPX4 Signaling Pathway. Drug Design Development and Therapy. Volume 18. 6313–6329. 2 indexed citations
2.
Wang, Jun, Weichao Tu, Jianxin Qiu, & Dawei Wang. (2022). Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma. Frontiers in Pharmacology. 13. 984080–984080. 3 indexed citations
3.
Gu, Wei, Fangming Zhu, Dan Li, et al.. (2020). PARP-1 inhibitor-AG14361 suppresses acute allograft rejection via stabilizing CD4+FoxP3+ regulatory T cells. Pathology - Research and Practice. 216(8). 153021–153021. 10 indexed citations
4.
Wu, Qi, Xiaoqing Zhou, Peng Li, et al.. (2019). High NRBP1 expression promotes proliferation and correlates with poor prognosis in bladder cancer. Journal of Cancer. 10(18). 4270–4277. 10 indexed citations
5.
Wang, Jun, Qi Wu, & Jianxin Qiu. (2019). Accumulation of fructose 1,6-bisphosphate protects clear cell renal cell carcinoma from oxidative stress. Laboratory Investigation. 99(6). 898–908. 16 indexed citations
6.
Wang, Jun, Mingyue Tan, Jifu Ge, et al.. (2018). Lysosomal acid lipase promotes cholesterol ester metabolism and drives clear cell renal cell carcinoma progression. Cell Proliferation. 51(4). e12452–e12452. 22 indexed citations
7.
Tao, Le, Jianxin Qiu, Ming Jiang, et al.. (2016). Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals. Molecular Cancer Therapeutics. 15(8). 1943–1951. 18 indexed citations
8.
Jia, Yichen, Bo Peng, Long Li, et al.. (2016). Estimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium. Therapeutic Drug Monitoring. 39(1). 29–36. 16 indexed citations
9.
Qiu, Jianxin, et al.. (2015). Improved Adaptive Genetic Algorithm in Optimal Layout of Leather Rectangular Parts. 8(3). 20–26. 3 indexed citations
10.
Tan, Mingyue, Yigang Zeng, Le Tao, et al.. (2014). Downregulation of Homeodomain‐Interacting Protein Kinase‐2 Contributes to Bladder Cancer Metastasis by Regulating Wnt Signaling. Journal of Cellular Biochemistry. 115(10). 1762–1767. 26 indexed citations
11.
Zhou, Zhihua, Yong Liu, Fang Zhang, et al.. (2014). Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis. Experimental Cell Research. 331(2). 399–407. 18 indexed citations
12.
Zeng, Yigang, Zhihong Liu, Yong Liu, et al.. (2014). Impact of HLA Antibodies on Graft Survival in Long-Term Renal Recipients with Functional Grafts. Urologia Internationalis. 92(3). 328–333. 3 indexed citations
13.
Luo, Ming, Zuowei Li, Wei Wang, et al.. (2013). Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS Journal. 280(7). 1709–1716. 124 indexed citations
14.
Tan, Mingyue, Xingyu Mu, Bin Liu, et al.. (2013). SUMO-Specific Protease 2 Suppresses Cell Migration and Invasion through Inhibiting the Expression of MMP13 in Bladder Cancer Cells. Cellular Physiology and Biochemistry. 32(3). 542–548. 33 indexed citations
15.
Xin, Binjie, et al.. (2012). Texture Modelling of Fabric Appearance Evaluation Based on Image Analysis. Fibres and Textiles in Eastern Europe. 48–52. 4 indexed citations
16.
Li, Zuowei, Ming Luo, Jianxin Qiu, et al.. (2012). Detection of Antibodies Against Major Histocompatibility Complex Class I-Related Chain A in Long-term Renal Graft Recipients. Experimental and Clinical Transplantation. 10(3). 239–242. 9 indexed citations
17.
Qiu, Jianxin. (2011). Measurement and Classification of Shanghai Female Face Shape Based on 3D Image Feature. 1 indexed citations
18.
Qiu, Jianxin. (2009). Mammalian target of rapamycin inhibitors in the treatment of malignancy after organ transplantation.
19.
Tan, Ming Jen, et al.. (2005). Thirty years of kidney transplantation in two Chinese centers.. PubMed. 203–7. 4 indexed citations
20.
Qiu, Jianxin, et al.. (2004). [Study of sensitivity to impulse noise in guinea pig, rat and mouse].. PubMed. 39(8). 472–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026